World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
42455
World Ranking
11998
National Ranking
6151

Overview

Desmond A. Schatz is affiliated with the University of Florida in the United States. Their research primarily spans the fields of Medicine, with a focus on Endocrinology, Diabetes and Metabolism, as well as Genetics. The scientist's work engages extensively with subfields including Surgery, General Health Professions, and Infectious Diseases.

The main topics of research covered include:

  • Diabetes and associated disorders
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diabetes Treatment and Management
  • COVID-19 Clinical Research Studies
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diet and metabolism studies

Desmond A. Schatz has contributed to multiple recent publications, with selected works including:

  • Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice, 2022, Endocrine Reviews
  • A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial, 2021, The Lancet
  • Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals, 2021, Science Translational Medicine
  • Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes, 2020, Nature Medicine
  • A combined risk score enhances prediction of type 1 diabetes among susceptible children, 2020, Nature Medicine

The scientist frequently publishes in journals such as:

  • Diabetes
  • Diabetes Care
  • Diabetes Technology & Therapeutics
  • Diabetologia
  • JCI Insight

Collaborations are a significant aspect of Desmond A. Schatz's work, with frequent co-authors including:

  • Michael J. Haller
  • Laura M. Jacobsen
  • Mark A. Atkinson
  • Andrea K. Steck
  • Jorma Toppari

Best Publications

  • International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

    David M. Nathan;Beverly Balkau;Enzo Bonora;Knut Borch-Johnsen

  • Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    Tadej Battelino;Thomas Danne;Richard M. Bergenstal;Stephanie A. Amiel

  • Type 1 Diabetes Mellitus

    Anastasia Katsarou;Soffia Gudbjörnsdottir;Araz Rawshani;Dana Dabelea

  • Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association.

    Richard A. Insel;Jessica L. Dunne;Mark A. Atkinson;Jane L. Chiang

  • Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells.

    Vijayakumar K. Ramiya;Michael Maraist;Karl E. Arfors;Desmond A. Schatz

  • Effects of insulin in relatives of patients with type 1 diabetes mellitus

    J. S. Skyler;D. Brown;H. P. Chase;E. Collier

  • Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

  • An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    Kevan C. Herold;Brian N. Bundy;S. Alice Long;Jeffrey A. Bluestone

  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

    Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow

  • Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes

    S. Brian Wilson;Sally C. Kent;Kurt T. Patton;Tihamer Orban

  • Toward defining the autoimmune microbiome for type 1 diabetes

    Adriana Giongo;Kelsey A. Gano;David B. Crabb;Nabanita Mukherjee

  • Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes

    Christopher T. Brown;Austin G. Davis-Richardson;Adriana Giongo;Kelsey A. Gano

  • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Identification of tissue-specific cell death using methylation patterns of circulating DNA.

    Roni Lehmann-Werman;Daniel Neiman;Hai Zemmour;Joshua Moss

  • Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association

    Jane L. Chiang;David M. Maahs;Katharine C. Garvey;Korey K. Hood

  • Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes

    Todd M. Brusko;Clive H. Wasserfall;Michael J. Clare-Salzler;Desmond A. Schatz

  • The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.

    Jeffrey P. Krischer;Kristian F. Lynch;Desmond A. Schatz;Jorma Ilonen;Jorma Ilonen

  • A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.

    Riley Wj;Maclaren Nk;Krischer J;Spillar Rp

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Rituximab, B-lymphocyte depletion, and preservation of beta-cell function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

Frequent Co-Authors

Mark A. Atkinson
Mark A. Atkinson University of Florida
Clive Wasserfall
Clive Wasserfall University of Florida
Jeffrey P. Krischer
Jeffrey P. Krischer University of South Florida
Jay S. Skyler
Jay S. Skyler University of Miami
Todd M. Brusko
Todd M. Brusko University of Florida
Martha Campbell-Thompson
Martha Campbell-Thompson University of Florida
Carla J. Greenbaum
Carla J. Greenbaum Virginia Mason Medical Center
Noel K. Maclaren
Noel K. Maclaren Cornell University
Anette-G. Ziegler
Anette-G. Ziegler Technical University of Munich
Jin-Xiong She
Jin-Xiong She Jinfiniti Precision Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in medicine but want flexible or alternative pathways, there are several online options worth considering. For those interested in pharmaceutical careers, pharm d online programs provide a way to advance your expertise and credentials without relocating or putting your life on hold.

For individuals interested in the organizational side of healthcare, him programs equip students with the knowledge needed to manage medical data, technology, and compliance in hospitals and clinics.

Entry-level roles are also accessible through specialized courses. If you’re looking for fast-track options to join the healthcare field, billing and coding classes online can help you get started in administrative roles with high demand.

Lastly, nursing remains one of the most respected healthcare fields. Those wishing to increase their clinical skills while keeping costs manageable should explore the cheapest nurse practitioner programs, which enable working nurses to earn advanced degrees online and expand their professional opportunities.

Best Scientists Citing Desmond A. Schatz

Trending Scientists